Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
Actual shortage: | 226 (7%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2023-07-21 | 2023-08-18 | 199524 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-08-12 | 2023-08-18 | 201696 |
APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2023-09-01 | 2023-10-20 | 203560 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-09-15 | 2023-12-01 | 204411 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-09-15 | 2023-10-06 | 204420 |
APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2023-09-28 | 2024-01-05 | 205501 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-10-06 | 2023-12-01 | 206566 |
APO-LENALIDOMIDE | 20MG | CAPSULE | Resolved | 2023-10-20 | 2023-12-01 | 207695 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-20 | 2023-11-10 | 207719 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-11-10 | 2024-01-19 | 209945 |
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2023-11-17 | 2024-01-12 | 210683 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-12-08 | 2023-12-15 | 212937 |
APO-MYCOPHENOLATE | 250MG | CAPSULE | Actual shortage | 2023-12-08 | 2024-01-19 | 212958 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-01-05 | 2024-02-02 | 215221 |
APO-PREGABALIN | 150MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216726 |
APO-PREGABALIN | 225MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216729 |
APO-PREGABALIN | 25MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216732 |
APO-PREGABALIN | 300MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216735 |
APO-PREGABALIN | 50MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216738 |
APO-PREGABALIN | 75MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216741 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |